ClinVar Miner

Submissions for variant NM_005732.4(RAD50):c.2498_2499del (p.Gln833fs)

gnomAD frequency: 0.00006  dbSNP: rs587782895
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000132534 SCV000187631 pathogenic Hereditary cancer-predisposing syndrome 2021-06-25 criteria provided, single submitter clinical testing The c.2498_2499delAA pathogenic mutation, located in coding exon 15 of the RAD50 gene, results from a deletion of two nucleotides at nucleotide positions 2498 to 2499, causing a translational frameshift with a predicted alternate stop codon (p.Q833Rfs*11). This pathogenic mutation was observed in a study of high-risk breast cancer patients who underwent multi-gene panel testing (Lin PH et al. Oncotarget 2016 Feb;7(7):8310-20). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Invitae RCV000132534 SCV000548004 pathogenic Hereditary cancer-predisposing syndrome 2023-12-17 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Gln833Argfs*11) in the RAD50 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAD50 are known to be pathogenic (PMID: 19409520). This variant is present in population databases (rs587782895, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with breast cancer (PMID: 26824983). ClinVar contains an entry for this variant (Variation ID: 143015). For these reasons, this variant has been classified as Pathogenic.
Counsyl RCV000662958 SCV000785928 pathogenic Nijmegen breakage syndrome-like disorder 2018-01-15 criteria provided, single submitter clinical testing
Baylor Genetics RCV000662958 SCV004207421 pathogenic Nijmegen breakage syndrome-like disorder 2022-12-27 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.